Test of a clip system during open liver surgery
Part of Digestive system clinical trials.
This trial studies a new clip system (ABSOLOK™) used during open liver operations. It aims to improve how surgeons control or manage parts of the liver during surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must agree to join the study and sign the consent form
- You must be scheduled for open (not keyhole) liver surgery
- Your surgery cannot be an emergency operation
- Your surgery cannot be done using laparoscopy (keyhole surgery)
- You should not need a connection between bile ducts and the intestine during surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how patients recover after having part of their liver or bile ducts surgically removed at a specialized center. Researchers will review medical records and follow-ups to understand which patients do well and identify ways to improve care.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This trial studies whether a simple “white test” using a special lipid (fat-like) solution can help the surgical team spot open bile ducts early during liver removal. Finding them sooner may help prevent bile leakage after liver surgery.
This trial looks at how major liver surgery with controlled blood flow (vascular clamping) affects patients. It may help doctors improve outcomes for people who need this type of operation.
This trial tests whether using stroke volume variation (SVV) is better than central venous pressure (CVP) to guide fluid management and reduce bleeding during open liver surgery. It aims to find a safer way to manage fluids during the operation.
This study tests whether a surgical procedure (splenectomy with azygoportal disconnection) combined with a lipid-lowering medication (LSD) can improve cholesterol levels and reduce bleeding complications in people with advanced liver disease. Researchers will follow participants for 2 years to measure changes in blood lipids and overall health.
Hear when a new Bile Leak trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.